Yan WT - Search Results

1

Predictors and long-term prognosis of early and late recurrence for patients undergoing hepatic resection of hepatocellular carcinoma: a large-scale multicenter study.

Yan WT, Li C, Yao LQ, Qiu HB, Wang MD, Xu XF, Zhou YH, Wang H, Chen TH, Gu WM, Zhong JH, Wu H, Pawlik TM, Lau WY, Shen F, Yang T. Yan WT, et al. Hepatobiliary Surg Nutr. 2023 Apr 10;12(2):155-168. doi: 10.21037/hbsn-21-288. Epub 2021 Oct 21. Hepatobiliary Surg Nutr. 2023. PMID: 37124678 Free PMC article.

2

An unusual primary hepatic lymphoma.

Yu JJ, Yan WT, Li C, Yang T. Yu JJ, et al. Among authors: yan wt. Dig Liver Dis. 2018 Aug;50(8):855. doi: 10.1016/j.dld.2018.02.016. Epub 2018 Mar 3. Dig Liver Dis. 2018. PMID: 29625909 No abstract available.

3

Relationship between complications and long-term prognosis after total gastrectomy with splenectomy for proximal advanced gastric cancer.

Quan B, Yan WT, Yu JJ, Shen F, Yang T. Quan B, et al. Among authors: yan wt. Eur J Surg Oncol. 2019 Nov;45(11):2230. doi: 10.1016/j.ejso.2018.05.023. Epub 2018 Jun 5. Eur J Surg Oncol. 2019. PMID: 29909045 No abstract available.

4

Propensity score analyses of long-term outcomes of perivascular hepatocellular carcinoma: Radiofrequency ablation vs. surgery.

Xu XF, Xing H, Yan WT, Wang JH, Yang T. Xu XF, et al. Among authors: yan wt. Hepatobiliary Pancreat Dis Int. 2018 Oct;17(5):482. doi: 10.1016/j.hbpd.2018.09.005. Epub 2018 Sep 13. Hepatobiliary Pancreat Dis Int. 2018. PMID: 30253945 No abstract available.

5

Impact of delayed time from diagnosis to treatment on the stage of hepatocellular carcinoma.

Quan B, Yan WT, Lau WY, Wu MC, Yang T. Quan B, et al. Among authors: yan wt. Hepatobiliary Pancreat Dis Int. 2019 Feb;18(1):100. doi: 10.1016/j.hbpd.2018.09.019. Epub 2018 Sep 27. Hepatobiliary Pancreat Dis Int. 2019. PMID: 30314770 No abstract available.

6

Identification of Actual 10-Year Survival After Hepatectomy of HBV-Related Hepatocellular Carcinoma: a Multicenter Study.

Li ZL, Yan WT, Zhang J, Zhao YJ, Lau WY, Mao XH, Zeng YY, Zhou YH, Gu WM, Wang H, Chen TH, Han J, Xing H, Wu H, Li C, Wang MD, Wu MC, Shen F, Yang T. Li ZL, et al. Among authors: yan wt. J Gastrointest Surg. 2019 Feb;23(2):288-296. doi: 10.1007/s11605-018-4006-4. Epub 2018 Oct 17. J Gastrointest Surg. 2019. PMID: 30334177

7

Tissue and serum metabolite profiling reveals potential biomarkers of human hepatocellular carcinoma.

Han J, Qin WX, Li ZL, Xu AJ, Xing H, Wu H, Zhang H, Wang MD, Li C, Liang L, Quan B, Yan WT, Shen F, Wu MC, Yang T. Han J, et al. Among authors: yan wt. Clin Chim Acta. 2019 Jan;488:68-75. doi: 10.1016/j.cca.2018.10.039. Epub 2018 Oct 31. Clin Chim Acta. 2019. PMID: 30389456

8

Statins, diabetes, obesity, nonalcoholic fatty liver disease, and hepatocellular carcinoma.

Han J, Yan WT, Quan B, Wang MD, Yang T. Han J, et al. Among authors: yan wt. Hepatobiliary Pancreat Dis Int. 2019 Apr;18(2):202. doi: 10.1016/j.hbpd.2018.10.004. Epub 2018 Nov 16. Hepatobiliary Pancreat Dis Int. 2019. PMID: 30473472 No abstract available.

9

Time to recurrence, but not recurrence-free survival, should be the endpoint used to predict early recurrence after HCC resection.

Yan WT, Quan B, Xing H, Wu MC, Yang T. Yan WT, et al. J Hepatol. 2019 Mar;70(3):570-571. doi: 10.1016/j.jhep.2018.10.025. Epub 2018 Dec 13. J Hepatol. 2019. PMID: 30553526 No abstract available.

10

Should we invariably follow the current guidelines to treat our HCC patients?

Yan WT, Quan B, Yu JJ, Yang T. Yan WT, et al. Hepatobiliary Pancreat Dis Int. 2019 Jun;18(3):301-302. doi: 10.1016/j.hbpd.2019.01.005. Epub 2019 Jan 21. Hepatobiliary Pancreat Dis Int. 2019. PMID: 30686653 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

54 results

Search Page

Filters